TLSA
TLSA
NASDAQ · Biotechnology

Tiziana Life Sciences Ltd

$1.36
+0.09 (+7.09%)
As of Feb 8, 2:07 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 60.16M 53.18M 50.95M
Net Income -7,561,680 -6,775,030 -7,233,045
EPS
Profit Margin -12.6% -12.7% -14.2%
Rev Growth -4.1% +12.5% -5.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 71.73M 85.83M 81.65M
Total Equity 58.15M 60.02M 66.17M
D/E Ratio 1.23 1.43 1.23
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -8,587,792 -7,436,735 -8,070,839
Free Cash Flow -10,429,515 -10,842,286 -7,296,543